Type 2 SLE Symptoms Persist Despite Type 2 Medication Polypharmacy
Publication
, Conference
Whitney, R; Eudy, A; Coffman, C; Clowse, M; Criscione-Schreiber, L; Doss, J; Sadun, R; Sun, K; Rogers, J
Published in: ARTHRITIS & RHEUMATOLOGY
2020
Duke Scholars
Published In
ARTHRITIS & RHEUMATOLOGY
EISSN
2326-5205
ISSN
2326-5191
Publication Date
2020
Volume
72
Related Subject Headings
- 3204 Immunology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Whitney, R., Eudy, A., Coffman, C., Clowse, M., Criscione-Schreiber, L., Doss, J., … Rogers, J. (2020). Type 2 SLE Symptoms Persist Despite Type 2 Medication Polypharmacy. In ARTHRITIS & RHEUMATOLOGY (Vol. 72).
Whitney, Raeann, Amanda Eudy, Cynthia Coffman, Megan Clowse, Lisa Criscione-Schreiber, Jayanth Doss, Rebecca Sadun, Kai Sun, and Jennifer Rogers. “Type 2 SLE Symptoms Persist Despite Type 2 Medication Polypharmacy.” In ARTHRITIS & RHEUMATOLOGY, Vol. 72, 2020.
Whitney R, Eudy A, Coffman C, Clowse M, Criscione-Schreiber L, Doss J, et al. Type 2 SLE Symptoms Persist Despite Type 2 Medication Polypharmacy. In: ARTHRITIS & RHEUMATOLOGY. 2020.
Whitney, Raeann, et al. “Type 2 SLE Symptoms Persist Despite Type 2 Medication Polypharmacy.” ARTHRITIS & RHEUMATOLOGY, vol. 72, 2020.
Whitney R, Eudy A, Coffman C, Clowse M, Criscione-Schreiber L, Doss J, Sadun R, Sun K, Rogers J. Type 2 SLE Symptoms Persist Despite Type 2 Medication Polypharmacy. ARTHRITIS & RHEUMATOLOGY. 2020.
Published In
ARTHRITIS & RHEUMATOLOGY
EISSN
2326-5205
ISSN
2326-5191
Publication Date
2020
Volume
72
Related Subject Headings
- 3204 Immunology
- 3202 Clinical sciences